Anti-IL-17 therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Anti-IL-17 therapy, covering 2017-11-30 to 2017-11-30. Get the full timeline:
Most recent: Clinical Trial Update: Mechanism of Action of Anti-IL17 Therapy in Peripheral Spondyloarthritis [Phase 3]